Brain Stimulation and Cognitive Training

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT03338673
Collaborator
(none)
12
1
2
11.5
1

Study Details

Study Description

Brief Summary

People with serious mental illness often report difficulties with thinking skills like memory. These difficulties can make it harder to perform day-to-day activities. The purpose of this study is to test whether combining a type of non-invasive brain stimulation with computerized cognitive exercises is acceptable to participants, and whether it is helpful in improving a specific type of memory skill in people who have mental health conditions and memory deficits.

This study is designed so that all participants will get both treatments: the non-invasive brain stimulation and computerized cognitive exercises. Half of the participants will start with both the brain stimulation and the cognitive exercises (dual therapy), and half will start with just the computerized exercises (monotherapy). After three weeks, participants will switch to the other condition: the people who did both treatments first will switch to just the cognitive exercises alone, and the people who started with the cognitive exercises alone will then switch to doing both the brain stimulation and cognitive exercises.

Overall, participants will be in the study for about 7-8 weeks. The brain stimulation treatment involves 10 visits to the clinic over 3 weeks. The computerized cognitive exercises can be done at home, and involve 10 hours of exercises over 3 weeks. Participants will also complete paper-and-pencil assessments at the beginning, middle, and end of treatment.

Condition or Disease Intervention/Treatment Phase
  • Device: tDCS
  • Other: BrainHQ
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Participants will be randomized to receive either dual therapy (cognitive exercises plus brain stimulation) or monotherapy (cognitive exercises alone) first; after 3 weeks participants will switch to the other conditionParticipants will be randomized to receive either dual therapy (cognitive exercises plus brain stimulation) or monotherapy (cognitive exercises alone) first; after 3 weeks participants will switch to the other condition
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Neuromodulation Plus Cognitive Training to Improve Working Memory Among Individuals With Serious Mental Illness.
Actual Study Start Date :
Oct 11, 2018
Actual Primary Completion Date :
Sep 27, 2019
Actual Study Completion Date :
Sep 27, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dual Therapy First

Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone

Device: tDCS
tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function
Other Names:
  • Transcranial direct current stimulation
  • Other: BrainHQ
    BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    Other Names:
  • Computerized cognitive exercises
  • Experimental: Mono Therapy First

    Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises

    Device: tDCS
    tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function
    Other Names:
  • Transcranial direct current stimulation
  • Other: BrainHQ
    BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    Other Names:
  • Computerized cognitive exercises
  • Outcome Measures

    Primary Outcome Measures

    1. Participant Retention in Combination Treatment [4 weeks]

      Number of participants completing every session of the combined phase of treatment

    2. Participant-rated Acceptability of Combination Therapy [8 weeks]

      Self-reported satisfaction as indicated on a numerical rating scale (1-10, where higher scores indicate greater satisfaction)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of bipolar disorder I or II, schizoaffective disorder, or schizophrenia

    • Objective cognitive impairment in working memory

    • Willingness to complete computerized cognitive training and undergo brain stimulation procedures

    Exclusion Criteria:
    • History of neurological illness or brain injury (e.g., stroke)

    • History of loss of consciousness

    • Diagnosed intellectual disability

    • Current substance use disorder

    • Current mania or moderate depression or severe psychosis

    • Serious suicidal ideation/behavior

    • Pregnant or trying to become pregnant, or currently lactating

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Michigan Ann Arbor Michigan United States 48109

    Sponsors and Collaborators

    • University of Michigan

    Investigators

    • Principal Investigator: Cynthia Burton, PhD, University of Michigan

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Cynthia Burton, Clinical Lecturer, Department of Psychiatry, University of Michigan
    ClinicalTrials.gov Identifier:
    NCT03338673
    Other Study ID Numbers:
    • HUM00119204
    First Posted:
    Nov 9, 2017
    Last Update Posted:
    Sep 2, 2020
    Last Verified:
    Aug 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Dual Therapy First Mono Therapy First
    Arm/Group Description Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    Period Title: Overall Study
    STARTED 6 6
    COMPLETED 5 5
    NOT COMPLETED 1 1

    Baseline Characteristics

    Arm/Group Title Dual Therapy First Mono Therapy First Total
    Arm/Group Description Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Total of all reporting groups
    Overall Participants 6 6 12
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    48.67
    (13.98)
    48.83
    (13.41)
    48.75
    (13.06)
    Sex: Female, Male (Count of Participants)
    Female
    5
    83.3%
    5
    83.3%
    10
    83.3%
    Male
    1
    16.7%
    1
    16.7%
    2
    16.7%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    3
    50%
    1
    16.7%
    4
    33.3%
    White
    3
    50%
    5
    83.3%
    8
    66.7%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%

    Outcome Measures

    1. Primary Outcome
    Title Participant Retention in Combination Treatment
    Description Number of participants completing every session of the combined phase of treatment
    Time Frame 4 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Dual Therapy First Mono Therapy First
    Arm/Group Description Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    Measure Participants 6 6
    Count of Participants [Participants]
    4
    66.7%
    5
    83.3%
    2. Primary Outcome
    Title Participant-rated Acceptability of Combination Therapy
    Description Self-reported satisfaction as indicated on a numerical rating scale (1-10, where higher scores indicate greater satisfaction)
    Time Frame 8 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Dual Therapy First Mono Therapy First
    Arm/Group Description Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    Measure Participants 5 5
    Mean (Standard Deviation) [units on a scale]
    9.40
    (0.89)
    8.60
    (2.07)

    Adverse Events

    Time Frame 8 weeks
    Adverse Event Reporting Description
    Arm/Group Title Dual Therapy First Mono Therapy First
    Arm/Group Description Participants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory Participants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises tDCS: tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function BrainHQ: BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
    All Cause Mortality
    Dual Therapy First Mono Therapy First
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/6 (0%) 0/6 (0%)
    Serious Adverse Events
    Dual Therapy First Mono Therapy First
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/6 (0%) 0/6 (0%)
    Other (Not Including Serious) Adverse Events
    Dual Therapy First Mono Therapy First
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/6 (0%) 0/6 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Cynthia Burton
    Organization University of Michigan
    Phone 7347639259
    Email czburton@umich.edu
    Responsible Party:
    Cynthia Burton, Clinical Lecturer, Department of Psychiatry, University of Michigan
    ClinicalTrials.gov Identifier:
    NCT03338673
    Other Study ID Numbers:
    • HUM00119204
    First Posted:
    Nov 9, 2017
    Last Update Posted:
    Sep 2, 2020
    Last Verified:
    Aug 1, 2020